285 related articles for article (PubMed ID: 11006045)
21. A successful live twin birth by in vitro fertilization after conservative treatment of recurrent endometrial cancer.
Wu HM; Lai CH; Huang HY; Wang HS; Soong YK
Chang Gung Med J; 2008; 31(1):102-6. PubMed ID: 18419059
[TBL] [Abstract][Full Text] [Related]
22. Successful pregnancies in 2 infertile patients with endometrial adenocarcinoma.
Nakao Y; Nomiyama M; Kojima K; Matsumoto Y; Yamasaki F; Iwasaka T
Gynecol Obstet Invest; 2004; 58(2):68-71. PubMed ID: 15103232
[TBL] [Abstract][Full Text] [Related]
23. Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases.
Signorelli M; Caspani G; Bonazzi C; Chiappa V; Perego P; Mangioni C
BJOG; 2009 Jan; 116(1):114-8. PubMed ID: 19087082
[TBL] [Abstract][Full Text] [Related]
24. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
Hurst SA; Hartzfeld KM; Del Priore G
Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger.
Ota T; Yoshida M; Kimura M; Kinoshita K
Int J Gynecol Cancer; 2005; 15(4):657-62. PubMed ID: 16014120
[TBL] [Abstract][Full Text] [Related]
26. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations.
Imai M; Jobo T; Sato R; Kawaguchi M; Kuramoto H
Eur J Gynaecol Oncol; 2001; 22(3):217-20. PubMed ID: 11501776
[TBL] [Abstract][Full Text] [Related]
27. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH
Eur J Cancer; 2013 Mar; 49(4):868-74. PubMed ID: 23072814
[TBL] [Abstract][Full Text] [Related]
28. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
Hahn HS; Yoon SG; Hong JS; Hong SR; Park SJ; Lim JY; Kwon YS; Lee IH; Lim KT; Lee KH; Shim JU; Mok JE; Kim TJ
Int J Gynecol Cancer; 2009 Aug; 19(6):1068-73. PubMed ID: 19820370
[TBL] [Abstract][Full Text] [Related]
29. [Two cases of endometrial stromal sarcoma (ESS) in which survival was prolonged by administration of MPA].
Ishibashi M; Nakayama K; Shamima Y; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gan To Kagaku Ryoho; 2008 May; 35(5):857-61. PubMed ID: 18487930
[TBL] [Abstract][Full Text] [Related]
30. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
Park JY; Lee SH; Seong SJ; Kim DY; Kim TJ; Kim JW; Kim JH; Kim YM; Kim YT; Bae DS; Nam JH
Gynecol Oncol; 2013 Apr; 129(1):7-11. PubMed ID: 23283299
[TBL] [Abstract][Full Text] [Related]
31. Assisted reproductive technologies in conjunction with conservatively treated endometrial adenocarcinoma. A case report.
Ogawa S; Koike T; Shibahara H; Ohwada M; Suzuki M; Araki S; Sato I
Gynecol Obstet Invest; 2001; 51(3):214-6. PubMed ID: 11306913
[TBL] [Abstract][Full Text] [Related]
32. A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively.
Yarali H; Bozdag G; Aksu T; Ayhan A
Fertil Steril; 2004 Jan; 81(1):214-6. PubMed ID: 14711571
[TBL] [Abstract][Full Text] [Related]
33. Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature.
Ohyagi-Hara C; Sawada K; Aki I; Mabuchi S; Kobayashi E; Ueda Y; Yoshino K; Fujita M; Tsutsui T; Kimura T
Arch Gynecol Obstet; 2015 Jan; 291(1):151-7. PubMed ID: 25118836
[TBL] [Abstract][Full Text] [Related]
34. Progesterone treatment decreases sulfate carbohydrate antigen on endometrial carcinoma cells and inhibits the cell binding to laminin.
Kawakita M; Tsuji Y; Nakata Y; Ogasawara T; Takemura T; Isojima S; Koyama K
Gynecol Oncol; 1995 Jun; 57(3):313-20. PubMed ID: 7539773
[TBL] [Abstract][Full Text] [Related]
35. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
[TBL] [Abstract][Full Text] [Related]
36. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
Corrado G; Baiocco E; Carosi M; Vizza E
Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
[TBL] [Abstract][Full Text] [Related]
37. Endometrial carcinoma in septate uterus detected 6 months after full-term delivery: case report and review of the literature.
Itoh K; Shiozawa T; Shiohara S; Ashida T; Konishi I
Gynecol Oncol; 2004 Apr; 93(1):242-7. PubMed ID: 15047244
[TBL] [Abstract][Full Text] [Related]
38. Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma.
Elizur SE; Beiner ME; Korach J; Weiser A; Ben-Baruch G; Dor J
Fertil Steril; 2007 Dec; 88(6):1562-7. PubMed ID: 17412340
[TBL] [Abstract][Full Text] [Related]
39. Well-differentiated endometrial adenocarcinoma in an infertility patient with later conception. A case report.
Kowalczyk CL; Malone J; Peterson EP; Jacques SM; Leach RE
J Reprod Med; 1999 Jan; 44(1):57-60. PubMed ID: 9987742
[TBL] [Abstract][Full Text] [Related]
40. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
